Case File №
#VI-2026-0979
Peptronix Bio PTB
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
36 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | B Good | 8 | 7.2 | 5.7 | 8.0 | 5 Aug 2025 |
| Tirzepatide | B Good | 5 | 7.4 | 5.8 | 9.2 | 25 Jul 2025 |
| 4-Anilinopiperidine CAS 99918-43-1 | X N/A | 1 | 7.8 | 7.8 | 7.8 | 8 Jul 2025 |
| ACE-031 | X N/A | 1 | 7.0 | 7.0 | 7.0 | 14 Jan 2025 |
| AICAR Oral | X N/A | 1 | 7.1 | 7.1 | 7.1 | 3 Jul 2025 |
| Anavar (Oxandrolone) Raw | X N/A | 1 | 5.0 | 5.0 | 5.0 | 24 Apr 2025 |
| ARA-290 | X N/A | 1 | 8.0 | 8.0 | 8.0 | 21 May 2025 |
| Boldenone Cypionate | X N/A | 1 | 6.3 | 6.3 | 6.3 | 11 Jun 2025 |
| BPC-157 Arg Oral | X N/A | 1 | 6.7 | 6.7 | 6.7 | 25 Apr 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 6.8 | 6.8 | 6.8 | 17 Dec 2024 |
| Cartalax | X N/A | 1 | 7.7 | 7.7 | 7.7 | 9 Jun 2025 |
| Cerebrolysin | X N/A | 1 | 7.6 | 7.6 | 7.6 | 21 May 2025 |
| Chonluten | X N/A | 1 | 6.2 | 6.2 | 6.2 | 2 Apr 2025 |
| CJC-1295 With DAC | X N/A | 1 | 7.8 | 7.8 | 7.8 | 8 Jul 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 5.5 | 5.5 | 5.5 | 28 Mar 2025 |
| COCK BOMBS (Viagra 50mg + Cialis 20mg) | X N/A | 1 | 5.6 | 5.6 | 5.6 | 25 Apr 2025 |
| DHB (1-Test Cyp) Oral | X N/A | 1 | 7.4 | 7.4 | 7.4 | 20 Jun 2025 |
| DHT (Stanolone) | X N/A | 1 | 9.6 | 9.6 | 9.6 | 14 Jan 2025 |
| Dianabol | X N/A | 1 | 7.9 | 7.9 | 7.9 | 11 Jun 2025 |
| Drostanolone Enanthate (Mast E) Raw | X N/A | 1 | 4.8 | 4.8 | 4.8 | 21 May 2025 |
| Drostanolone Propionate (Mast P) Raw | X N/A | 1 | 6.5 | 6.5 | 6.5 | 20 Jun 2025 |
| Enclomiphene | X N/A | 1 | 9.8 | 9.8 | 9.8 | 2 Apr 2025 |
| HMG | X N/A | 1 | 5.4 | 5.4 | 5.4 | 27 Feb 2025 |
| Letrozole | X N/A | 1 | 4.7 | 4.7 | 4.7 | 28 Mar 2025 |
| Liraglutide | X N/A | 1 | 7.0 | 7.0 | 7.0 | 6 May 2025 |
| MENT (Trestolone Acetate) | X N/A | 1 | 6.1 | 6.1 | 6.1 | 3 Jun 2025 |
| MOTS-C | X N/A | 1 | 5.8 | 5.8 | 5.8 | 14 Jan 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 9.3 | 9.3 | 9.3 | 25 Apr 2025 |
| NAD+ Injectable | X N/A | 1 | 8.9 | 8.9 | 8.9 | 14 Jan 2025 |
| Nandrolone Decanoate (Deca) Raw | X N/A | 1 | 7.6 | 7.6 | 7.6 | 7 May 2025 |
| PE 22-28 | X N/A | 1 | 9.2 | 9.2 | 9.2 | 21 May 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 7.7 | 7.7 | 7.7 | 8 Jul 2025 |
| Super Shred | X N/A | 1 | 9.1 | 9.1 | 9.1 | 3 Jul 2025 |
| Testosterone Base Micro Raw | X N/A | 1 | 7.7 | 7.7 | 7.7 | 25 Apr 2025 |
| Vesugen | X N/A | 1 | 6.5 | 6.5 | 6.5 | 17 Dec 2024 |
| Winstrol (Stanozolol) | X N/A | 1 | 8.5 | 8.5 | 8.5 | 2 Jul 2025 |
Exhibit II
Evidence Log
41 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.7 A | 30mg | 32.3mg | +7.7% | 95.58% | v9p25t | Lab F | Public |
| 24 May 2026 | MENT (Trestolone Acetate) | 7.6 A | 300mg/ml | 269.1mg/ml | -10.3% | 97.15% | guuxga | Lab D | Community |
| 24 May 2026 | Nandrolone Decanoate (Deca) Raw | 5.1 B | 500g | 566.3g | +13.3% | 97.05% | h1u44f | Lab C | Community |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 7.5 A | 50mg | 45.4mg | -9.2% | 96.65% | r31dod | Lab A | Community |
| 24 May 2026 | MOTS-C | 5.2 B | 50mg | 56.0mg | +11.9% | 96.62% | 2g786j | Lab G | Public |
| 24 May 2026 | BPC-157 Arg Oral | 7.4 A | 100mg | 109.1mg | +9.1% | 97.79% | vtec7k | Lab F | Public |
| 24 May 2026 | Drostanolone Enanthate (Mast E) Raw | 5.4 B | 5g | 5.8g | +16.2% | 95.69% | kw57da | Lab G | Public |
| 24 May 2026 | Anavar (Oxandrolone) Raw | 5.7 B | 10g | 8.7g | -12.7% | 99.70% | 9krr3r | Lab B | Community |
| 23 May 2026 | AICAR Oral | 5.7 B | 100mg | 122.9mg | +22.9% | 96.92% | ehjgco | Lab B | Community |
| 23 May 2026 | Selank 10mg + Semax 10mg Blend | 6.4 A | 15mg | 15.7mg | +4.8% | 96.28% | 0defub | Lab B | Community |
| 22 May 2026 | Retatrutide | 5.7 C | 20mg | 22.5mg | +12.5% | 99.81% | (no batch ID) | Lab E | Public |
| 21 May 2026 | Winstrol (Stanozolol) | 7.6 A | 10mg | 8.7mg | -13.3% | 99.33% | mfjwsj | Lab G | Public |
| 21 May 2026 | Tirzepatide | 6.3 B | 10mg | 11.1mg | +11.0% | 99.90% | (no batch ID) | Lab E | Public |
| 21 May 2026 | Tirzepatide | 5.8 C | 30mg | 32.5mg | +8.3% | 99.46% | (no batch ID) | Lab E | Public |
| 20 May 2026 | Retatrutide | 6.3 B | 10mg | 11.1mg | +11.0% | 99.90% | (no batch ID) | Lab E | Public |
| 20 May 2026 | Boldenone Cypionate | 5.1 B | 100mg/ml | 113.0mg/ml | +13.0% | 99.05% | 2i2hhp | Lab E | Community |
| 19 May 2026 | DHB (1-Test Cyp) Oral | 6.7 A | 100mg | 97.6mg | -2.4% | 95.84% | 7y9s2j | Lab D | Public |
| 19 May 2026 | NAD+ Injectable | 9.8 A | 100mg/ml | 90.7mg/ml | -9.3% | 97.50% | um855k | Lab D | Public |
| 17 May 2026 | ARA-290 | 9.6 A | 2mg | 2.4mg | +18.8% | 99.13% | ns7h6g | Lab E | Public |
| 17 May 2026 | Liraglutide | 4.0 C | 10mg | 12.4mg | +24.4% | 99.45% | w57udi | Lab A | Public |
| 29 Jan 2026 | Cartalax | 7.0 A | 5mg | 5.4mg | +8.5% | 96.66% | rmnp40 | Lab F | Public |
| 29 Jan 2026 | Testosterone Base Micro Raw | 7.4 A | 5g | 4.3g | -13.3% | 96.92% | bjbe7m | Lab E | Public |
| 26 Jan 2026 | Super Shred | 8.3 A | 200mg/ml | 174.3mg/ml | -12.9% | 98.61% | loncpg | Lab C | Public |
| 19 Jan 2026 | COCK BOMBS (Viagra 50mg + Cialis 20mg) | 6.4 A | 20mg | 21.7mg | +8.7% | 97.25% | yprxsb | Lab F | Public |
| 7 Jan 2026 | Retatrutide | 6.7 B | 15mg | 16.1mg | +7.3% | 99.70% | (no batch ID) | Lab G | Public |
| 7 Jan 2026 | ACE-031 | 5.1 B | 15mg | 15.8mg | +5.0% | 97.67% | 9vl1nt | Lab G | Public |
| 7 Jan 2026 | Chonluten | 7.0 A | 15mg | 16.2mg | +7.7% | 98.72% | 48m2d5 | Lab F | Community |
| 29 Dec 2025 | DHT (Stanolone) | 10.0 A | 100mg/ml | 108.3mg/ml | +8.3% | 98.23% | xpf4w9 | Lab D | Public |
| 29 Dec 2025 | Dianabol | 8.2 A | 50mg | 57.9mg | +15.8% | 95.74% | d5de36 | Lab E | Public |
| 12 Dec 2025 | Vesugen | 7.1 A | 30mg | 34.9mg | +16.4% | 95.74% | r9srtw | Lab B | Community |
| 6 Dec 2025 | Retatrutide | 8.0 A | 30mg | 31.3mg | +4.3% | 99.95% | (no batch ID) | Lab E | Public |
| 5 Dec 2025 | 4-Anilinopiperidine CAS 99918-43-1 | 7.0 A | 500g | 482.1g | -3.6% | 95.13% | qo3r38 | Lab G | Public |
| 5 Dec 2025 | Letrozole | 6.9 A | 20mg | 20.6mg | +2.8% | 97.71% | 2m9ouk | Lab B | Public |
| 14 Nov 2025 | HMG | 5.8 B | 5mg | 4.3mg | -13.2% | 97.81% | dczv8e | Lab B | Public |
| 14 Nov 2025 | N-Acetyl Epitalon Amidate | 8.4 A | 5mg | 5.4mg | +8.5% | 99.30% | eztqa5 | Lab A | Community |
| 6 Nov 2025 | Retatrutide | 8.0 A | 10mg | 9.58mg | -4.2% | 99.88% | (no batch ID) | Lab E | Public |
| 5 Nov 2025 | Cerebrolysin | 8.1 A | 10mg | 10.2mg | +1.5% | 98.88% | 6ioyjp | Lab A | Community |
| 5 Nov 2025 | Enclomiphene | 8.9 A | 50mg | 55.4mg | +10.8% | 97.93% | ao6y3h | Lab C | Community |
| 17 Oct 2025 | PE 22-28 | 7.5 A | 20mg | 19.0mg | -4.8% | 98.74% | ivoahf | Lab C | Community |
| 9 Oct 2025 | CJC-1295 With DAC | 5.6 B | 15mg | 17.8mg | +19.0% | 99.42% | coyvh1 | Lab E | Public |
| 9 Oct 2025 | Drostanolone Propionate (Mast P) Raw | 6.4 A | 100g | 113.1g | +13.1% | 96.29% | ko8p7h | Lab B | Public |
— END OF EVIDENCE LOG —